In addition to being positive for vimentin, these sarcomas may be positive for either SMA and/or desmin (15,32,33), resulting in desmin(+)/SMA(−), desmin(−)/SMA(+) and desmin(+)/SMA(+) immunophenotypes. This evidence concerns the gene DES and sarcoma.